Paper930755
New orally effective chromosome derivatives for the treatment of asthma.
Augstein J and 9 others. Agents Actions, 1977. Cited by 42 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. New orally effective chromosome derivatives for the treatment of asthma. Papers, record 930755. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/930755
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Chromones | Major topic |
| Animals | |
| Basophils | |
| Bronchi | |
| Humans | |
| Immunoglobulin E | |
| In Vitro Techniques | |
| Passive Cutaneous Anaphylaxis | |
| Rats |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 813,078 | The effect of predosage with disodium cromoglycate (DSCG) on the dose-related inhibition of rat passive cutaneous anaphylaxis by DSCG. | Life Sci | 1975 | https://conductscience.org/library/papers/813078 | PubMed |
| 2 | 48,779 | Doxantrazole, an antiallergic agent orally effective in man. | Lancet | 1975 | https://conductscience.org/library/papers/48779 | PubMed |
| 3 | 4,201,413 | Inhibition of allergic reactions by cromoglycate and by AH 7079 in patients with allergic airway disease. | Int Arch Allergy Appl Immunol | 1973 | https://conductscience.org/library/papers/4201413 | PubMed |
| 4 | 4,596,403 | Inhibition of experimental asthma in man by a new drug (AH 7725) active when given by mouth. | Br Med J | 1974 | https://conductscience.org/library/papers/4596403 | PubMed |
| 5 | 4,099,491 | Disodium cromoglycate (Intal). | Adv Drug Res | 1970 | https://conductscience.org/library/papers/4099491 | PubMed |
| 6 | 4,100,689 | Degranulation of human basophil leukocytes by anti-gamma E antibody. | J Immunol | 1971 | https://conductscience.org/library/papers/4100689 | PubMed |
| 7 | 4,181,251 | Histamine release from human leukocytes by anti-gamma E antibodies. | J Immunol | 1969 | https://conductscience.org/library/papers/4181251 | PubMed |
| 8 | 4,306,785 | Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate. | Immunology | 1969 | https://conductscience.org/library/papers/4306785 | PubMed |
| 9 | 4,123,820 | Inhibition of immediate hypersensitivity reactions by disodium cromoglycate. | Clin Exp Immunol | 1973 | https://conductscience.org/library/papers/4123820 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,334,039 | Therapeutic potency of substituted chromones as Alzheimer's drug: Elucidation of acetylcholinesterase inhibitory activity through spectroscopic and molecular modelling investigation. | Bioimpacts | 2019 | https://conductscience.org/library/papers/31334039 | PubMed |
| 25,758,539 | A one-pot three-component reaction involving 2-aminochromone in aqueous micellar medium: a green synthesis of hexahydrochromeno[2,3-b]quinolinedione. | Mol Divers | 2015 | https://conductscience.org/library/papers/25758539 | PubMed |
| 6,781,575 | The pharmacology of isamoxole [2-methyl-n-butyl-n(4-methyloxazol-2-yl) propanamide] LRCL 3950, a new anti-allergic compound. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/6781575 | PubMed |
| 6,653,614 | Metabolism and clearance of proxicromil--studies in rat, hamster, rabbit, dog, squirrel monkey, cynomolgus monkey, baboon and man. | Eur J Drug Metab Pharmacokinet | 1983 | https://conductscience.org/library/papers/6653614 | PubMed |
| 6,456,651 | The activity of an anti-allergic compound, proxicromil, on models of immunity and inflammation. | Agents Actions | 1981 | https://conductscience.org/library/papers/6456651 | PubMed |
| 6,159,030 | The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/6159030 | PubMed |
| 6,155,772 | Oxatomide: inhibition and stimulation of histamine release from human lung and leucocytes in vitro. | Agents Actions | 1980 | https://conductscience.org/library/papers/6155772 | PubMed |
| 2,574,532 | The effect of leukotriene antagonists, lipoxygenase inhibitors and selected standards on leukotriene-mediated allergic bronchospasm in guinea pigs. | Agents Actions | 1989 | https://conductscience.org/library/papers/2574532 | PubMed |
| 115,253 | The effect of lodoxamide ethyl [diethyl N,N'-(2-chloro-5-cyano-m-phenylene)dioxamate] on in vivo anaphylactic reactions. | Agents Actions | 1979 | https://conductscience.org/library/papers/115253 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/930755
GET https://conductscience.org/api/papers/v1/930755/authors